Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways

Li-min Kang(Puer University), Lang Li(Puer University)
Journal of Microbiology and Biotechnology
November 20, 2024
Cited by 12


Related Papers